Point72 Asset Management, L.P. 13D and 13G filings for Merrimack Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:04 pm Sale | 2022-12-31 | 13G | Merrimack Pharmaceuticals, Inc. MACK | Point72 Asset Management, L.P. | 0 0.000% | -900,981 (Position Closed) | Filing |
| 2022-08-04 4:28 pm Purchase | 2022-08-03 | 13G | Merrimack Pharmaceuticals, Inc. MACK | Point72 Asset Management, L.P. | 900,981 6.700% | 900,981 (New Position) | Filing |